More Information for Better Decisions

Ethos Laboratories has entered a strategic partnership with Genscript to offer the first Surrogate Viral Neutralizing Test (sVNT) to evaluate COVID-19 protective immunity in the United States. This test, marketed as Tru-Immune™, will measure and quantify the neutralizing capacity of antibodies against the SARS-CoV-2 virus. Unlike other tests currently on the market, Tru-Immune™ detects the presence and magnitude of functional antibodies that prevent infectivity of the COVID 19 virus. Please fill out the contact form for more information.

For more information, submit your inquiry below: